Effects of iron and carbon monoxide on Lachesis muta muta venom-mediated degradation of plasmatic coagulation

V G Nielsen1, R W Matika1

  • 1Department of Anesthesiology, University of Arizona College of Medicine, Tucson, AZ, USA.

Insights

Iron and carbon monoxide protect human plasma from Lachesis muta muta venom

Area of Science:

  • Biochemistry
  • Toxicology
  • Hematology

Background:

  • Hypofibrinogenemia is a significant clinical issue after Lachesis muta muta envenomation.
  • Lachesis muta muta venom contains fibrinogenolytic metalloproteinase and thrombin-like serine protease enzymes.
  • Iron (Fe) and carbon monoxide (CO) exposure can reduce fibrinogen catalysis by these enzymes.

Purpose of the Study:

  • To investigate the protective effects of Fe and CO on human plasma coagulation against Lachesis muta muta venom.
  • To differentiate the impact of Fe and CO on the venom's metalloproteinase and thrombin-like enzyme activities.

Main Methods:

  • Thrombelastographic analytical techniques were employed.
  • Human plasma was pretreated with Fe and CO.
  • Experiments involved heparin and varying calcium concentrations.
  • Venom was exposed to CO in isolation before plasma addition.

Main Results:

  • Fe and CO pretreatment of plasma significantly attenuated venom-induced hypofibrinogenemia and procoagulant effects.
  • Fe and CO modification rendered fibrinogen unrecognizable to the metalloproteinase but not the thrombin-like enzyme.
  • CO exposure inhibited the venom's fibrinogenase but not its thrombin-like enzyme activity.

Conclusions:

  • Fe and/or CO addition offers protection against the fibrinogenolytic activity of Lachesis muta muta venom.
  • These modifications do not inhibit the thrombin-like enzyme's procoagulant effects.
  • Facile modifications with Fe and CO show potential in mitigating specific venom-induced coagulation disturbances.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.7K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.6K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
3.5K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
15.9K
The Periodic Table and Organismal Elements00:57

The Periodic Table and Organismal Elements

Overview
205.1K